[Fetopathy associated with exposure to angiotensin converting enzyme inhibitors].
Angiotensin Converting Enzyme Inhibitors (ACEI) are commonly used antihypertensive drugs, although contraindicated during pregnancy by fetopathy association such as renal dysgenesis, oligohydramnios, hipocalvaria, pulmonary hypoplasia, intrauterine growth restriction, and neonatal anuric renal failure. The authors present a clinical report of a child that developed neonatal anuric renal failure with peritoneal dialysis support by an in uterus exposure to ACEI with very good recovery. This case and literature review states the need to avoid ACEI prescription to Young women and it's suspension as soon as possible during pregnancy.
Neves
Sérgio
S
Unidade de Nefrologia Pediátrica, Hospital Pediátrico de Coimbra, Coimbra.
Santos
Raquel
R
Gomes
Clara
C
Correia
António Jorge
AJ
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D001002:Anuria / Q000139:chemically induced*; D002675:Child, Preschool; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced*; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D051437:Renal Insufficiency / Q000139:chemically induced*
D000806:Angiotensin-Converting Enzyme Inhibitors